Study Stopped
School closures during COVID-19 precluded study activities
Web-based Professional Development for SMHPs in Evidence-Based Practices for Attention and Behavior Challenges
CLS-R
1 other identifier
interventional
79
1 country
2
Brief Summary
This study develops a web-based PD (CLS-R) to provide SSWs with remote training in EBPs for attention and behavior problems. CLS-R is designed to be usable, feasible, portable, accessible, and acceptable - ingredients which have been identified as necessary for the sustainability of school-based programs. The study evaluates the usability, feasibility, acceptability, fidelity of implementation, and preliminary effects on student outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2017
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedFirst Submitted
Initial submission to the registry
October 31, 2022
CompletedFirst Posted
Study publicly available on registry
February 6, 2023
CompletedFebruary 6, 2023
January 1, 2023
2.8 years
October 31, 2022
January 26, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Symptoms of Attention Deficit Hyperactivity Disorder as defined by DSMV
Parent and teacher rating scale
Change from baseline to post-treatment
Secondary Outcomes (8)
Homework Problems Checklist (HPC)
Change from baseline to post-treatment
Children's Organizational Skills Scale (COSS)
Change from baseline to post-treatment
Symptoms of Oppositional Defiant Disorder as defined by DSMV
Change from baseline to post-treatment
Strengths and Difficulties Questionnaire
Change from baseline to post-treatment
Clinical Global Improvement
Change from baseline to post-treatment
- +3 more secondary outcomes
Study Arms (2)
CLS-R
EXPERIMENTALWeb-based remote training for school mental health providers
CLS
ACTIVE COMPARATORIn-person training for school mental health providers
Interventions
CLS-R Training includes school provider training in CLS via web platform and videoconferencing for workshops, consultation and coaching.CLS is a 10-12 week program and includes school, parent, and student components which are integrated via joint teacher, parent, and student meetings and use of integrated behavioral programs in the classroom and home.
Eligibility Criteria
You may qualify if:
- Children ages 7-11, 2nd-5th grades
- Presence of academic and social problems related to inattention and/or hyperactivity/impulsivity (as judged by school SSW)
- Six or more inattention symptoms and/or six or more hyperactive/impulsive symptoms endorsed across parent and teacher rating scales (using an either-or algorithm, such that a symptom is counted as being present if either parent or teacher endorses it as occurring 'often' or 'very often')
- Functional impairment reported by either parent or teacher on the IRS (score of 3 or greater)
- Caretaker available and consents to participate in treatment
- Currently attending a participating school full-time
You may not qualify if:
- Presence of conditions that are incompatible with this study's treatment:
- severe visual or hearing impairment,
- severe language delay,
- psychosis,
- pervasive developmental disorder
- Parent or child does not read or speak English or does not read or speak Spanish for our Spanish language implementation of CLS (inability to complete assessment measures or participate in group treatments).
- Child is in an all-day special education classroom (children in these classrooms are frequently receiving intensive behavior modification programs such that the intervention would be expected to require modification for use in these settings)
- Children taking psychotropic medication for any reason other than to treat ADHD
- Children planning to change (start or stop) psychotropic medication
- Children who have changed a regimen of psychotropic medication (started or stopped) within 30 days prior to screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
HALP Clinic, Children's Center at Langley Porter, UCSF
San Francisco, California, 94143, United States
University of California San Francisco
San Francisco, California, 94143, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Linda Pfiffner, PhD
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2022
First Posted
February 6, 2023
Study Start
September 1, 2017
Primary Completion
June 30, 2020
Study Completion
June 30, 2020
Last Updated
February 6, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share